Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|December 22, 2020
- December 2020
- Volume 88
- Issue 12
Pet Peeves (December 2020)
Brought to you by The Sassy Pharmacist.
Advertisement
Brought to you by The Sassy Pharmacist.
OPTICAL ILLUSION
When the patient tells you they watched the doctor send the prescription.
FALSE PHONE CALL
When patients call the Doctor Line.
DRIVE-THROUGH DELIVERY
When they call to ask you to grab items to get at the drive-through window.
PUSHING MY BUTTONS
When they push the button at the drive through window and they just pulled up.
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to [email protected]. We’ll share them in print and online.
Articles in this issue
over 5 years ago
Pharmacists Play a Vital Role in Diabetes Managementover 5 years ago
Consider Impact of Certain Medications on Brain Functionover 5 years ago
Select High-Alert Medications Require Cautionover 5 years ago
Statins Are the Cornerstone of Lowering Cholesterol Levelsover 5 years ago
Acute Coronary Syndrome Is a Medical Emergencyover 5 years ago
Providers Have Duty to Warn About Patient Threatsover 5 years ago
Thrifty Mac Pharmacy Delights Patients and StaffAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
2
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
3
FDA Reduces Monitoring Time for First Two Tarlatamab Doses
4
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
5